Massachusetts Requires ABA Therapy Coverage for Down Syndrome

Inside the Massachusetts Mandate

BOSTON, MASSACHUSETTS — Chapter 388 of the Acts of 2024 took effect January 1, 2026, requiring most Massachusetts health insurers, MassHealth plans, and the state employee group plan to cover applied behavior analysis therapy for individuals with a sole diagnosis of Down syndrome. Governor Maura Healey signed the bill on January 9, 2025, after the Massachusetts Down Syndrome Congress had carried it as a top legislative priority since 2019.

Before the change, Massachusetts insurers covered ABA primarily for individuals with an autism spectrum disorder diagnosis. Patients with both Down syndrome and ASD could access ABA through the dual diagnosis. Patients with Down syndrome alone could not. The National Down Syndrome Society estimates that 16 to 18 percent of individuals with Down syndrome also have ASD, leaving the remainder, more than four in five, outside the existing coverage framework.

The Center for Health Information and Analysis (CHIA), the state agency that reviews mandated benefit bills, examined the predecessor legislation in August 2023 and projected that the bill would mainly extend ABA coverage to that previously excluded population. The CHIA review used Massachusetts All Payer Claims Database data to size the population of members under age 65 in the fully insured commercial market with a Down syndrome diagnosis and no co-occurring ASD diagnosis.

The Massachusetts mandate is among the most expansive standalone state expansions of ABA coverage in over a decade. Florida’s 2008 autism statute also includes Down syndrome treatment, but it is structured as part of an autism mandate and carries a $36,000 annual benefit cap and a $200,000 lifetime cap. The Massachusetts law sits across separate sections of the General Laws and contains no comparable dollar limits.

Massachusetts is the first state in nearly two decades to enact a standalone insurance mandate covering ABA therapy for individuals with a sole Down syndrome diagnosis, and the first to do so without dollar or lifetime caps.

Where Provider Tech Stacks Fall Short

For ABA providers in Massachusetts, the immediate operational challenge is technology. Practice management and electronic health record systems used across the industry, including CentralReach, Motivity, and Catalyst by Rethink, were designed around ABA’s historical eligibility framework, in which an autism spectrum disorder diagnosis triggers ABA coverage. Eligibility verification, authorization workflows, and claims submission rules embedded in those platforms assume that ABA is an autism-specific service.

The Massachusetts mandate breaks that assumption. Providers must reconfigure their systems to recognize Down syndrome (ICD-10 code Q90 and its subcategories) as a primary qualifying diagnosis for ABA, rather than treating it only as a co-occurring condition alongside ASD. The required updates touch intake forms, eligibility verification, authorization request templates, and claims edit logic.

Hi Rasmus, an ABA technology platform, published guidance on January 4, 2026 noting that providers will need their systems to capture Down syndrome diagnosis data accurately, support outcomes measurement across multiple neurodevelopmental profiles, and segment client cohorts for reporting and quality improvement. The platform highlighted the need for clinical teams to adapt individualized treatment plans for the Down syndrome population, whose learning profile and behavioral patterns differ from those of individuals with autism.

Billing and Authorization Realignment

The billing implications extend beyond a diagnosis code change. Payers are issuing new medical necessity guidelines specifically for ABA services for individuals with Down syndrome. Point32Health, the parent company of Harvard Pilgrim Health Care and Tufts Health Plan, announced in October 2025 that effective January 1, 2026, it would replace its existing ABA medical necessity guidelines and use updated InterQual SmartSheets for prior authorization review across its Harvard Pilgrim Commercial, Tufts Health Plan Commercial, Tufts Health Direct, and Tufts Health Together products.

For ABA billing staff, authorization requests for clients with a sole Down syndrome diagnosis will follow different criteria than authorization requests for autism patients. The medical necessity narrative, treatment goals, and outcome measures must be framed for the Down syndrome population’s clinical needs rather than mapped to autism-specific tools and language. Practices that submit authorizations using autism-specific templates for Down syndrome clients are likely to see denials and delays.

The ABA-specific CPT codes (97151 through 97158, the adaptive behavior service codes) are not diagnosis-specific. They describe the service delivered, not the condition treated, and in principle apply to ABA services for Down syndrome clients on the same basis as autism clients. Payer-specific billing rules, modifier requirements, and place-of-service codes can vary, and practices must verify each payer’s specific billing guidance for Down syndrome ABA before submitting.

On the Medicaid side, MassHealth administers ABA benefits through three managed care behavioral health networks: MBHP/Carelon (Massachusetts Behavioral Health Partnership), Tufts Health Public Plans, and Optum Behavioral Health. Each will need to update credentialing, authorization, and claims adjudication systems to recognize the new Down syndrome eligibility. The pace of those updates will determine how quickly providers can deliver and bill for ABA services for the new population.

Clinical Adaptation for a New Population

The technology and billing changes are real, but the deeper challenge is clinical. ABA for individuals with Down syndrome requires meaningful adaptations from protocols that BCBAs have built for the autism population. Down syndrome is a chromosomal condition caused by an extra whole or partial copy of chromosome 21, and its clinical presentation includes intellectual disability, hypotonia, speech and language delays, and learning profiles that differ from the autism phenotype.

BCBAs working with Down syndrome clients must adapt assessment tools, goal selection frameworks, and intervention strategies. The behavioral excesses and skill deficits that define autism, including restricted and repetitive behaviors, social communication deficits, and sensory processing differences, are not necessarily the primary treatment targets in this population. ABA for Down syndrome may center more heavily on adaptive living skills, communication augmentation, academic readiness, and behavior management in educational environments.

The clinical adaptation requirement carries workforce implications. BCBAs in Massachusetts have trained almost exclusively in autism-focused ABA, and few graduate-level ABA programs include a curriculum on applying ABA principles to Down syndrome or other non-autism neurodevelopmental conditions. Providers accepting Down syndrome clients under the new mandate will need to invest in training, supervision, and quality assurance to ensure services meet the standard of care that payers will require for reimbursement.

If the clinical evidence supports ABA for Down syndrome, the same logic applies to other non-autism neurodevelopmental conditions, raising a coverage question the industry has not yet had to answer at scale.

The Massachusetts mandate also raises a question for the broader ABA industry. If payers and clinicians accept the case for ABA coverage in Down syndrome, the same arguments apply to other non-autism neurodevelopmental conditions, including ADHD, intellectual disabilities, and traumatic brain injury. Each expansion would create the same cascade of system, billing, and clinical adaptation challenges.

What Comes Next for Providers

For practice owners in Massachusetts, the operational priorities are concrete. Update eligibility logic to recognize Down syndrome as a qualifying ABA diagnosis. Verify each commercial payer’s authorization criteria and billing rules. Train clinical staff on population-specific assessment and treatment planning. Establish quality assurance for a clinical population most BCBAs have limited experience serving.

Massachusetts payer policy updates are still rolling out. Point32Health’s February 2026 provider bulletin clarified that authorization requests should be submitted under the practice’s billing NPI rather than an individual therapist’s NPI, an adjustment that affected providers across both Harvard Pilgrim and Tufts Health Plan products. MassHealth has not yet issued centralized guidance for Down syndrome ABA billing across its three behavioral health networks, and providers should expect additional payer-specific authorization criteria through Q2 and Q3 2026.

AT A GLANCE

SOURCES & REFERENCES